Is MPO Activity and MDA a Marker of Determine Coronary Artery Disease in Non Diabetic Metabolic Syndrome Subjects

PP-280 This clinical study aimed to investigate MPO (myeloperoxidase) activity that is a marker of inflammatory and oxidative stress, is weather or not a marker to determine stable CAD (coronary artery disease) in MetS (metabolic syndrome) and to show the association between MPO activity and other